Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Rextar Pro

K-Number: K242185 · 2024-12-04

Decision Date2024-12-04
Product CodeEHD
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Rextar Pro is a medical device manufactured by Raypia Co., Ltd.. It received FDA 510(k) clearance on 2024-12-04 under approval number K242185. The device is classified under product code EHD. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Rextar Pro?

Rextar Pro is a medical device that received FDA 510(k) clearance on 2024-12-04. It is manufactured by Raypia Co., Ltd.. The 510(k) number is K242185.

When was Rextar Pro approved by the FDA?

Rextar Pro received FDA 510(k) clearance on 2024-12-04, under approval number K242185.

What company makes Rextar Pro?

Rextar Pro is manufactured by Raypia Co., Ltd..

What is the FDA product code for Rextar Pro?

The FDA product code for Rextar Pro is EHD.

Related Devices (Code: EHD)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.